Back to search

National and Kapodistrian University of Athens

Ανάπτυξη βιοδραστικών ενώσεων έναντι χρόνιων φλεγμονωδών νόσων στοχεύοντας την ενεργοποίηση παθογόνων ινοβλαστών

Abstract

dc:description

Fibroblasts play a crucial role in regulating inflammation, fibrosis, and cancer. Today, more than 50% of all deaths are attributed to inflammation-related diseases, while fibrotic diseases contributed to 17.8% in 2019. In terms of cancer, there were 9.7 million cancer-related deaths worldwide in 2022. Targeting fibroblast activation in these complex diseases has recently emerged as a novel approach to restore tissue homeostasis. In this study, we present a multidisciplinary approach for the discovery of small molecule lead compounds that inhibit pathogenic fibroblast activation. Our research involves initially the design and synthesis of novel bioactive compounds through exploration of extensive structure-activity relationship (SAR) and bioisosterism studies. The resulting benzamide derivatives were initially screened for their anti-inflammatory activity using phenotypic assays, while the biopharmaceutical properties (ADMET) of the most promising compounds were evaluated in vitro. To this end, robust synthetic procedures which are amenable to the parallel synthesis of derivatives were designed and applied, while our screening pipeline allowed us to discriminate key structural components against deactivating fibroblasts, to refine atoms or groups that favor a desirable ADMET profile, as well as to identify metabolic “hot-spots” of the new pharmacophore. Furthermore, the mechanism of action of the compounds was investigated by employing innovative cutting-edge techniques, such as chemoproteomics and RNA sequencing, followed by target validation experiments. In addition, preliminary pharmacokinetic and in vivo evaluation studies were performed for the most optimized derivatives. Notably, the current PhD thesis brings to light the first-in-class inhibitors for HYOU1 protein, a member of the HSP70 family linked to cellular stress responses. Therefore, targeting HYOU1 could offer a tractable approach to modulate fibroblast activation and address chronic inflammatory and fibrotic conditions.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mavrikaki, Vasiliki
  • Μαυρικάκη, Βασιλική

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57690

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mavrikaki, Vasiliki; Μαυρικάκη, Βασιλική. Ανάπτυξη βιοδραστικών ενώσεων έναντι χρόνιων φλεγμονωδών νόσων στοχεύοντας την ενεργοποίηση παθογόνων ινοβλαστών. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/57690